Andrew Geronimo, PhD

Dr. Andrew Geronimo's research interests broadly encompass the development of technology for the diagnosis, care and well-being of individuals with neurological disease. Much of his work is focused in the amytrophic lateral sclerosis (ALS) population, where he has studied brain-computer interface (BCI) assistive communication devices, tracked the use and efficacy of telehealth and developed telemonitoring tools for remote measurement of respiratory and ambulatory health.